RecruitingNCT03577327
The Gut and Skin Microbiome in Vitiligo Disease Progression
Sponsor
Northwestern University
Enrollment
100 participants
Start Date
May 30, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.
Eligibility
Min Age: 18 YearsMax Age: 89 Years
Inclusion Criteria4
- Patients with and/or without vitiligo lesional expansion over the past year.
- Age/sex-matched controls who do not have a diagnosis of vitiligo
- Subjects who are age 18-89 years of age at time of enrollment
- Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443)
Exclusion Criteria2
- Subjects who are younger than 18 years of age or 90 years of age or older
- Subjects who are unable to give consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03577327
Related Trials
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
NCT071696301 location
A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
NCT072847971 location
A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women
NCT076690771 location
PET Imaging of Noradrenergic Transmission in the Brain
NCT076863931 location
A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
NCT074073481 location